Which anticoagulant for stroke prevention in atrial fibrillation?

Affiliations

Editorial

Jocasta Ball. BMJ. 2017.

. 2017 Nov 28:359:j5399.

doi: 10.1136/bmj.j5399.

¹ Pre-Clinical Disease and Prevention, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia Jocasta.Ball@baker.edu.au.

No abstract available

Conflict of interest statement

Competing interests: I have read and understood the BMJ policy on declaration of interests and declare the following: none.

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savović J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R. López-López JA, et al. BMJ. 2017 Nov 28;359:j5058. doi: 10.1136/bmj.j5058. BMJ. 2017. PMID: 29183961 Free PMC article.